Clinical trial
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant…
NCT00463515 · University Hospital, Antwerp, Other · Completed
Key facts
| NCT number | NCT00463515 |
|---|---|
| Title | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC |
| Official title | A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer |
| Acronym | CHER@NOS |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Universiteit Antwerpen Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small-Cell-Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin/gemcitabine, cisplatin/radiation therapy |
| Enrollment | 77 |
| Start date | Jan 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 20, 2007 |
| Last update posted | Jul 12, 2013 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: